Harmonium Pharma was born in 2013 to offer people with diabetes concrete solutions to help them in the management of the disease and in the prevention of complications. The goal is to be the reference point in daily life for people living with this pathology by working in synergy with the main players operating in the world of diabetes: doctors, health personnel, institutions and associations of specialists and patients. Investments in Research and Development are continuous. The proactive and integrated research is focused on the development of innovative formulas and devices, biotechnologies and information systems. We work to build strong partnerships with recognized international players, in order to offer people with diabetes the best solutions currently on the market. We currently have distribution agreements in 20 countries to support people with diabetes with our products all around the world. We are always open to the acquisition and development of new products designed for the prevention of complications in the diabetic population. We aim for excellence. We have a transversal and prepared team, trained to grasp the trends of today and tomorrow to anticipate the needs of a constantly changing horizon. We work with the awareness that the human affinity of all the players in our network is the secret of success and the achievement of common goals. Please contact us at: info@harmonium-pharma.com
Looking for a particular Harmonium Pharma employee's phone or email?
The Harmonium Pharma annual revenue was $5.7 million in 2026.
Antonio D'Arco is the Coordinatore Nazionale Key Opinion Leaders e Rete Specialist of Harmonium Pharma.
9 people are employed at Harmonium Pharma.
Harmonium Pharma is based in Milan, Lombardy.
The NAICS codes for Harmonium Pharma are [3254, 325, 32541, 32].
The SIC codes for Harmonium Pharma are [283, 28].